ABC12: New drug kills metastatic melanoma
May 18, 2021
A team of scientists at the University of Cincinnati is developing a therapy that — when taken together — can improve existing melanoma treatments.
May 18, 2021
A team of scientists at the University of Cincinnati is developing a therapy that — when taken together — can improve existing melanoma treatments.
February 17, 2021
A researcher at the University of Cincinnati is studying whether electrical stimulation of the spinal cord can be helpful in treating certain psychiatric conditions, like depression.
March 12, 2021
For the first time, a visual correlation has been found between the severity of COVID-19 in the lungs using CT scans and the severity of effects on patient’s brains, using MRI scans, according to a new UC study.
March 16, 2021
Months after mammograms, colonoscopies and other routine cancer screenings, like lung cancer screenings, were suspended because of the pandemic, researchers are studying the impact.
December 17, 2020
A recent study led by University of Cincinnati Cancer Center researchers shows the impact the pandemic had on lung cancer screening, which experts say could be bad for both screening programs in general and for the overall well-being of patients.
July 21, 2020
National media outlets report on new UC findings that show immunotherapy will not worsen complications for patients who have cancer and COVID-19.
June 30, 2020
A researcher with the University of Cincinnati Gardner Neuroscience Institute thinks walking backward on a treadmill might help patients who have experienced stroke learn to walk again.
September 22, 2020
Drugs.com covers UC research looking at mortality in patients with cancer and COVID-19.
September 22, 2020
WVXU reports on a University of Cincinnati study showing cancer patients undergoing a combination of chemotherapy and immunotherapy one to three months before a COVID-19 diagnosis have a greater risk of death than patients who haven't undergone cancer treatment in the past year.
September 29, 2020
By examining preexisting research for other conditions, researchers at the University of Cincinnati have found a potential treatment that could be applied to COVID-19.